Lomevactone
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C18H17ClO2 |
| Molar mass | 300.78 g·mol−1 |
| 3D model (JSmol) | |
| |
Lomevactone (INN) (developmental code name DR-250) is a drug described as a psychostimulant and antidepressant which was synthesized and assayed in the 1980s but was never marketed.
Conformation
Another cas number is [75115-73-0]
It is the (3R,4R,6R)-form [82510-81-4] that contains the psychotherapeutic properties.
(Although the SSS isomer is depicted in the referenced diagram)
Synthesis
The conjugate 1,4-alkylation reaction between 4-chlorobenzylideneacetone [3160-40-5] (1) and phenylacetonitrile [140-29-4] (2) gives 3-(4-chlorophenyl)-5-oxo-2-phenylhexanenitrile, CID:333058 (3). The selective reduction of the keto group to the alcohol with sodium borohydride gives 3-(4-chlorophenyl)-5-hydroxy-2-phenylhexanenitrile, CID:12754889 (4). Hydrolysis of the nitrile to an acid would give 3-(4-Chlorophenyl)-5-hydroxy-2-phenylhexanoic acid, CID:3058345. This is followed by the concomitant lactone formation completing the synthesis of Lomevactone (5).
| |||||||||||||||||||||
| |||||||||||||||||||||
|
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| Adamantanes | |
|---|---|
| Adenosine antagonists | |
| Alkylamines | |
| Ampakines | |
| Arylcyclohexylamines | |
| Benzazepines | |
| Cathinones |
|
| Cholinergics |
|
| Convulsants | |
| Eugeroics | |
| Oxazolines | |
| Phenethylamines |
|
| Phenylmorpholines | |
| Piperazines | |
| Piperidines |
|
| Pyrrolidines | |
| Racetams | |
| Tropanes |
|
| Tryptamines | |
| Others |
|